Edible composition and dosage form comprising an edible shell
OwnerFrank J. Bunick, Gus B. LaBella +1inventors
InventorsFrank J. Bunick, Gus B. LaBella, Harry S. Sowden
Life of this patent
Estimating the term…
Loading patent…
OwnerFrank J. Bunick, Gus B. LaBella +1inventors
InventorsFrank J. Bunick, Gus B. LaBella, Harry S. Sowden
Estimating the term…
An edible product comprises at least about 50% by weight of a crystallizable carbohydrate based upon the weight of the product, wherein at least about 90% by weight of the crystallizable carbohydrate comprises crystals having an average particle size of about 100 microns or less, the product has a moisture content of not more than about 5% by weight loss on drying, at least about 30% of the cross-sectional area of the product is non-striated, and the edible product has a cross-sectional area in the range of about 1 to 900 sq. mm. A dosage form comprises at least one active ingredient and the edible product, or at least one active ingredient, a shell comprising the edible product, and a substrate such as a core. The shell or core or both may contain an active ingredient such as a pharmaceutically active ingredient.
An edible product comprising at least about 50% by weight of a crystallizable carbohydrate based upon the weight of the product, wherein at least about 90% by weight of the crystallizable carbohydrate comprises crystals having an average particle size of about 100 microns or less, the product has a moisture content of not more than about 5% by weight loss on drying, at least about 30% of the cross-sectional area of the product is non-striated, and the product has a cross-sectional area in the range of about 1 to 900 sq. mm.
A method of making an edible product, comprising:
An edible product prepared by a method comprising:
A dosage form comprising at least one active ingredient and an edible shell residing on at least a portion of a substrate, wherein the shell comprises at least about 50% by weight of a crystallizable carbohydrate based upon the weight of the shell, at least about 90% by weight of the crystallizable carbohydrate comprises crystals having an average particle size of about 100 microns or less, the shell has a moisture content of not more than about 5% by weight loss on drying, at least about 30% of the cross-sectional area of the shell is non-striated, and the dosage form has a cross-sectional area in the range of about 1 to 900 sq. mm.
A dosage form prepared by a method comprising:
A method of preparing a dosage form comprising:
A dosage form comprising at least one active ingredient and at least about 50% by weight of a crystallizable carbohydrate based upon the weight of the dosage form, wherein at least about 90% by weight of the crystallizable carbohydrate comprises crystals having an average particle size of about 100 microns or less, the dosage form has a moisture content of not more than about 5% by weight loss on drying, at least about 30% of the cross-sectional area of the dosage form is non-striated, and the dosage form has a cross-sectional area in the range of about 1 to 900 sq. mm.
Dependencies are inferred from the claim text.